VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1791612
Sex: F
Age:
State: IL

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210302; Test Name: Saliva rapid test; Test Result: Negative

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Pain under tongue and on the sides of tongue; Mouth pain; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Mar2021 at 09:30 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Feb2021 at 10:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 02Mar2021, at 11:00 the patient experienced mouth pain, specifically pain under tongue and on the sides of tongue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 02Mar2021, the patient underwent saliva rapid test and the result was negative. The clinical outcome of the event mouth pain and pain under tongue and on the sides of tongue were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791613
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: his wife is experiencing a severe diarrhea after she took the 1st dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date, the patient experienced experienced severe diarrhea after she took the 1st dose. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791614
Sex: M
Age:
State: NJ

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Muscle soreness at injection site (left arm); This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the left arm on 02Mar2021 at 10:45 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 03Mar2021 at 01:00, the patient experienced muscle soreness at injection site (left arm). The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event muscle soreness at injection site (left arm) was resolving at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791615
Sex: F
Age:
State: MS

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: ''My'' armpit started to hurt and it moved into my left breast. It hurt to the touch or to move; ''I'' read up on it and they call it Lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EN6203) via an unspecified route of administration in the left arm on 01Mar2021 at 09:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient received unspecified medication within two weeks of vaccination. On 02Mar2021 at 11:00, the patient experienced armpit started to hurt and it moved into her left breast. It hurt to the touch or to move. On 03Mar2021, the patient still felt it but not as bad. The patient would see how she felt throughout the day. She read up on it and called it Lymphadenopathy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events armpit started to hurt and lymphadenopathy was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791616
Sex: F
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Extreme pain, weakness and tightness in themuscles of legs; Weakness and tightness in themuscles of legs; Weakness and tightness in themuscles of legs; For 48 hours, could barely walk,; Makes it difficult to get up from a seated position; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6203) via an unspecified route of administration in the left arm on 24Feb2021 at 09:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included herniated discs in neck and penicillin allergy. Concomitant medications included cannabis sativa (MARIJUANA) for an unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 23:00, the patient experienced extreme pain, weakness and tightness in the muscles of her legs. For 48 hours, the patient could barely walk. The patient thought of going to Emergency Room (ER), but did not want COVID exposure. The pain was gone, but leg muscles remained very tight and made it difficult to get up from a seated position and the patient hoped legs would recover. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme pain, weakness and tightness in the muscles of legs was resolved on an unknown date in 2021; while that of the events weakness and tightness in the muscles of legs, for 48 hours could barely walk and makes it difficult to get up from a seated position was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: MARIJUANA

Current Illness:

ID: 1791617
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Arm soreness (Mild); This is a spontaneous report from a non-contactable consumer. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration on 02Mar2021 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On an unknown date in 2021, the patient experienced arm soreness (mild) and did not have redness at the injection site. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm soreness (mild) was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791618
Sex: M
Age:
State: PA

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Injection site right arm muscle pain; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 02Mar2021 at 15:15 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included Type 2 diabetes. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and sitagliptin phosphate (JANUVIA); both from unknown dates for unknown indications and unknown if ongoing. On 03Mar2021 at 00:00, the patient experienced injection site right arm muscle pain. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection site right arm muscle pain was unknown at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds: JANUVIA; METFORMIN

Current Illness:

ID: 1791619
Sex: F
Age:
State: VA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Migraine lasting at least 2 days; Ocular migraine; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 11:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 02Mar2021 at 16:00, the patient experienced migraine which lasted at least 2 days, ocular migraine and nausea. The events did not result in doctor or other healthcare professional office/clinic, and emergency room/department or urgent care. therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events migraine lasted at least 2 days, ocular migraine and nausea was resolving at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791620
Sex: F
Age:
State: NY

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Ringing in ears; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 01Mar2021 at 12:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. It was reported that the patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021 at 12:15, 15 minutes after the vaccination, the patient experienced ringing in ears. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing in ears was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791621
Sex: F
Age:
State: CT

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Moderate sore arm; Moderate headache; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 11:30(at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included intracranial hypertension and asthma. The patient had no known allergies to medications, food and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetazolamide (MANUFACTURER UNKNOWN) for an unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 15:00, the patient experienced moderate sore arm and moderate headache. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events moderate sore arm and moderate headache was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ACETAZOLAMIDE

Current Illness:

ID: 1791622
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Left arm sore to touch; Heavy feeling; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 11:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. On 02Mar2021 at 16:00, the patient experienced left arm sore to touch and heavy feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event Left arm sore to touch and heavy feeling was not recovered at time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791623
Sex: M
Age:
State: NJ

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Soreness on at the injection site; drowsiness during they day of theinjection; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration on 02Mar2021 at 10:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, the patient experienced Soreness on at the injection site and drowsiness during the day of the injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Soreness on at the injection site and drowsiness was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791624
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Low grade headache; Very tired; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 26Feb2021 at 08:15 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety. The patient had no known allergies. Concomitant medication included venlafaxine hydrochloride (EFFEXOR); taken for unknown indication from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Mar2021, the patient experienced low grade headache on monday/tuesday/wednesday the following week (as reported) and felt very tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade headache and very tired were unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: EFFEXOR

Current Illness:

ID: 1791625
Sex: F
Age:
State: NJ

Vax Date: 02/20/2021
Onset Date: 02/21/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Prolonged weakness through body; Major headache on right side; Chills; Body aches throughout; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 20Feb2021 at 15:30 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetic. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 29Jan2021 at 09:15 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. On 21Feb2021 at 11:00, the patient experienced prolonged weakness through body, major headache on right side, chills and body aches throughout. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events prolonged weakness through body, major headache on right side, chills and body aches throughout was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791626
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Nausea; Vomiting; Headache; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the right arm on 24Feb2021 at 10:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, hypertension, obesity and allergy to strawberries (fruit allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. The patient previously received zolpidem tartrate (AMBIEN) for unknown indication on an unknown date and experienced drug allergy. On 24Feb2021 at 10:30, the patient experienced nausea, vomiting, headache and loss of appetite. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nausea, vomiting, headache and loss of appetite was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791627
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Weakness; Nausea; Body aches; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG 202) via an unspecified route of administration in the left arm on 25Feb2021 at 02:30 (at the age of 67-years old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021, the patient experienced weakness, nausea, body aches and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events weakness, nausea, body aches and arm soreness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791628
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Abdominal pain; Runny diarrhea; This is a spontaneous report from a non-contactable other healthcare professional. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the right arm on 24Feb2021 at 16:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included lupus syndrome, congestive heart failure (CHF), sjogren's, rheumatoid arthritis, raynauds, endometriosis, depression, cardiomyopathy, penicillin allergy and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient received a long list of unspecified medications within two weeks of vaccination. The patient previously received hydroxyzine hydrochloride (HYDROXIZINE) and hydromorphone hydrochloride (DILAUDID) for an unknown indication on unknown date and experienced drug allergy. On 25Feb2021 at 16:00, the patient experienced abdominal pain and runny diarrhea. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room or department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events abdominal pain and runny diarrhea was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791629
Sex: F
Age:
State: GA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Nausea; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the arm left on 02Mar2021 at 13:15 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ethinylestradiol, norethisterone acetate (JUNEL) and dietary supplements; from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 13:15, the patient experienced nausea and dizziness. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea and dizziness were recovering at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: JUNEL

Current Illness:

ID: 1791630
Sex: F
Age:
State: NY

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: The day after receiving vaccine, a sore dime-sized red raised area developed. Each day the area has increased. Today the area is about the size of a slice of bread, red, slightly raised and tender to touch; The day after receiving vaccine, a sore dime-sized red raised area developed. Each day the area has increased. Today the area is about the size of a slice of bread, red, slightly raised and tender to touch; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 25Feb2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included ovarian cancer, thyroidectomy and wasp bites. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID), rucaparib camsylate (RUBRACA), warfarin sodium (COUMADIN), exemestane (MANUFACTURER UNKNOWN) and vitamin d nos (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 04Feb2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation and received cefaclor (CECLOR) and chlorhexidine topical scrub (MANUFACTURER UNKNOWN); both on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021 at 12:00, the day after receiving vaccination, the patient experienced a sore dime-sized red raised area developed. Each day the area had increased and at the day of reporting (Today) the area was about the size of a slice of bread, red, slightly raised and tender to touch. It looks similar to a response to wasp bites she had several years ago. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events a sore dime-sized red raised area and the area was about the size of a slice of bread, red, slightly raised and tender to touch was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; RUBRACA; COUMADIN; EXEMESTANE; VITAMIN D NOS

Current Illness:

ID: 1791631
Sex: M
Age:
State: WI

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: "I" was very light headed; "I" had chills; "I" felt fatigued; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 3248) via an unspecified route of administration in the left arm on 01Mar2021 at 14:30 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included lisinopril 10 mg (MANUFACTURER UNKNOWN) for unknown indication from unknown date and unknown if ongoing. On 02Mar2021 at 14:30, about 24 hours after the shot, the patient experienced very light headed and had chills. The patient felt fatigued as well. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events very light headed, chills and felt fatigued were resolved on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL

Current Illness:

ID: 1791632
Sex: F
Age:
State: IN

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Sore left side of left breast; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Feb2021 at 12:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN), multivitamin (MANUFACTURER UNKNOWN) and vitamin B complex (VITAMIN B) supplement, all taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021, the patient experienced sore left side of left breast. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore left side of left breast was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VITAMIN B [VITAMIN B COMPLEX]; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1791633
Sex: F
Age:
State: SC

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: arm pain; This is a spontaneous report from a contactable consumer (patient) via Regulatory Authority. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced arm pain. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791634
Sex: F
Age:
State: MN

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Soreness in left arm; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 02Mar2021 at 14:45 (at the age of 47-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to sulfa drugs and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included salbutamol (ALBUTEROL), levocetirizine dihydrochloride (XYZAL), montelukast (MANUFACTURER UNKNOWN) and unspecified vitamins; all taken for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Mar2021, at 21:00 the patient experienced soreness in left arm. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event soreness in left arm was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ALBUTEROL [SALBUTAMOL]; XYZAL; MONTELUKAST

Current Illness:

ID: 1791635
Sex: F
Age:
State: TX

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Hands and face burning; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 09:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial flutter, asthma, meniere's disease, blood pressure high and allergy to artificial dyes, penicillin, and yeast. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included PROPAFENONE, VERELAN, BENICAR, and CLOPIDOGREL, all for unknown indication from unknown date and unknown if ongoing. The patient previously received ASPIRIN, CIPRO, and LEVAQUIN, all on unknown date for unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 09:47, 17 minutes after vaccination, the patient experienced hands and face burning that lasted about 3 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event hands and face burning was recovered on 02Mar2021. No follow-up attempts are required, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PROPAFENONE; VERELAN; BENICAR; CLOPIDOGREL

Current Illness:

ID: 1791636
Sex: M
Age:
State: NY

Vax Date: 02/09/2021
Onset Date: 02/16/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Vertigo; dizziness accompanied by being light headed; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in the left arm on 09Feb2021 at 14:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN), chlortalidone (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), vitamin d not otherwise specified (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 19Jan2021 at 14:15 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. On 23Feb2021 at 05:30, the patient experienced vertigo and dizziness accompanied by being light headed started 14 days after the second dose. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events vertigo and dizziness was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN; CHLORTHALIDONE; LISINOPRIL; VITAMIN D NOS

Current Illness:

ID: 1791637
Sex: F
Age:
State: WA

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Neck stiffness; Soreness at injection site; Tiredness; Stomach cramping; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 02Mar2021 at 15:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included myasthenia gravis, fibromyalgia, osteoarthritis (OA), rheumatoid arthritis (RA), heart arrhythmia, asthma and allergy to bee venom. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The concomitant medications included gabapentin (MANUFACTURER UNKNOWN), flecainide (MANUFACTURER UNKNOWN), bupropion (MANUFACTURER UNKNOWN) and clotrimazole (MYCO) for unknown indications from unknown dates and unknown if ongoing. The patient previously took hydrocodone(MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. On 02Mar2021 at 19:45, the patient experienced neck stiffness, soreness at injection site, tiredness, stomach cramping and diarrhea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events neck stiffness, soreness at injection site, tiredness, stomach cramping and diarrhea was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; FLECAINIDE; BUPROPION; MYCO

Current Illness:

ID: 1791638
Sex: M
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Shoulder area of injection is moderately sore; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 25Feb2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date in Feb2021, the patient's shoulder area of injection was moderately sore. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shoulder area of injection is moderately sore was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791639
Sex: F
Age:
State: MI

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Sore area on back near spinal cord; Just an unusual feeling and uncomfortable when sat back; This is a spontaneous report from a contactable nurse, the patient. An 89-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 02Mar2021 at 14:00 (at the age of 89-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis and arthritis. The patient had no known allergies to food, medications or other products. Concomitant medications included acetylsalicylic acid (ASPIRIN) and hydrochorize; both for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the right arm on 09Feb2021 at 15:00 (at the age of 89-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, at 19:00 the patient experienced sore area on back near spinal cord; no marks, redness, or itchy. It was not a sharp pain, just an unusual feeling and uncomfortable when the patient sat back. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore area on back near spinal cord and just an unusual feeling and uncomfortable when sat back were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ASPIRIN

Current Illness:

ID: 1791640
Sex: M
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the arm right on 19Feb2021 at 14:30 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included raised blood pressure and facial pain. The patient did not had allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), irbesartan (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021 at 17:00, the patient experienced injection site soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection site soreness was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAMADOL; IRBESARTAN; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1791641
Sex: F
Age:
State: PA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Slight soreness at vaccination site; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 25Feb2021 at 11:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension (HTN) and increased cholesterol controlled with medications. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN) and unspecified vitamins (MANUFACTURE UNKNONWN); all for unknown indications, from an unknown date and unknown if ongoing. On 25Feb2021 at 23:00, the patient experienced slight soreness at vaccination site. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event slight soreness at vaccination site was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PRAVASTATIN; LISINOPRIL; CALCIUM.

Current Illness:

ID: 1791642
Sex: F
Age:
State: VA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: After about four hours after receiving the vaccine, my right breast implant swelled. I am a breast cancer survivor and after one week, the breast is still swollen. Going in for an ultrasound on 3/8.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Feb2021 at 12:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, breast cancer and atrial fibrillation (AFib). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Feb2021 at 16:00, after about four hours after receiving the vaccine, the patient experienced her right breast implant swelled. The patient reported that she was a breast cancer survivor and after one week, the breast was still swollen. The patient reported that she will be going in for an ultrasound on 08Mar2021.The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with steroids. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right breast implant swelled was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791643
Sex: M
Age:
State: MO

Vax Date: 02/11/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Pain in right fingers/ pain in right foot; Pain in knuckles; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Feb2021 at 13:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 18Feb2021 at 10:00, the patient experienced pain in right fingers, knuckles, and right foot. The patient did not receive any treatment for the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in right fingers/ pain in right foot and pain in knuckles was not resolved at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791644
Sex: F
Age:
State:

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Swollen lymph node in left arm pit; vaccine location=Left leg; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM3247) via an unspecified route of administration in the leg left on 15Feb2021 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Feb2021, 48 hours after the vaccination, the patient experienced swollen lymph node in left arm pit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node in left arm pit was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791645
Sex: M
Age:
State: CT

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210303; Test Name: Body temperature; Result Unstructured Data: Test Result: mild temperature elevation 1.5 degrees.

Allergies:

Symptom List: Tremor

Symptoms: Tiredness; Mild temperature elevation 1.5 degrees; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the right arm on 02Mar2021 at 09:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease, diabetes type 2, penicillin allergy, and sulfonamide allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 03Mar2021 at 07:00, the patient experienced tiredness and mild temperature elevation of 1.5 degrees. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. On 03Mar2021, the patient underwent body temperature test and the result was mild temperature elevation 1.5 degrees (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness and mild temperature elevation was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791646
Sex: F
Age:
State: CA

Vax Date: 02/17/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Red, swollen, warm-to-touch arm; Red, swollen, warm-to-touch arm; Red, swollen, warm-to-touch arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 17Feb2021 at 14:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received morphine and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included spironolactone (MANUFACTURER UNKNOWN) and pantoprazole sodium sesquihydrate (PROTONIX) all from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Feb2021, 8 days after vaccination, the patient experienced red, swollen and warm-to-touch arm. It was reported that welcome to contact her doctor but she did not go to show her reaction on her arm. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red, swollen, warm-to-touch arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SPIRONOLACTONE; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]

Current Illness:

ID: 1791647
Sex: F
Age:
State: KY

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Sore arm; Dull headache; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 02Mar2021 at 15:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included levothyroxine sodium (SYNTHROID), liothyronine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), vitamin d nos (VIT D) and zinc (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021 at 19:00, the patient experienced sore arm, dull headache and tiredness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, dull headache and tiredness were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SYNTHROID; LIOTHYRONINE; GABAPENTIN; VIT D [VITAMIN D NOS]; ZINC

Current Illness:

ID: 1791648
Sex: F
Age:
State:

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: ''I'' had a very violent episode of vertigo; Continued on and off dizziness since then but not as bad as the first day; This is a spontaneous report from a non-contactable consumer, the patient. A 68-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration on 08Feb2021 as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included bimatoprost (LUMIGAN), for an unknown indication from an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the right arm on 18Jan2021 as a single dose for COVID-19 immunisation. On 14Feb2021, about 6 days after vaccination, the patient had a very violent episode of vertigo. Continued on and off dizziness since then but not as bad as the first day (day 1 on 09Feb2021). She still had dizziness on and off throughout the day. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events very violent episode of vertigo and continued on and off dizziness were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LUMIGAN

Current Illness:

ID: 1791649
Sex: F
Age:
State: NJ

Vax Date: 03/02/2021
Onset Date: 03/03/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Woke up the next morning with left eye ball pain; Eye felt sunburned; Vision is slightly off; Eye felt sunburned, vision is slightly off, light sensitive; Saw eye doctor at 3:15, symptoms were still present, mild inflammation was visible during exam; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6205) via an unspecified route of administration in the left arm on 02Mar2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, vitamin b12 deficiency, allergy to latex, banana and avocado. The patient did not receive any medication within two weeks of vaccination. The patient previously received prednisone (MANUFACTURER UNKNOWN) and cortisone (MANUFACTURER UNKNOWN); and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient woke up the next morning on 03Mar2021 at 07:15, with left eye ball pain. Eye felt sunburned, vision was slightly off, light sensitive. The events resulted in doctor or other healthcare professional office/clinic visit. The patient saw eye doctor at 15:15, symptoms were still present, mild inflammation was visible during examination. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL) for pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left eye ball pain; eye felt sunburned, vision was slightly off, light sensitive; mild inflammation was visible during examination were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791650
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Hoarseness; a slight soar throat; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right upper arm on 25Feb2021 at 13:30 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic asthma under control with medication. The patient was not aware of any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ADVAIR and SPIRIVA inhalers for asthma, from an unknown date. On 25Feb2021 at 14:45, the patient experienced hoarseness and a slight sore throat, much better on reported day (01Mar2021) and hoarseness was not as bad as the first day. It was reported that the patient wanted to know if she would have the same problem when she receives the 2nd dose which was set for 18Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hoarseness and a slight sore throat was resolving at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVAIR; SPIRIVA

Current Illness:

ID: 1791651
Sex: F
Age:
State: TX

Vax Date: 02/01/2021
Onset Date: 02/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Strong dizziness/ dizzy, sometime more, sometimes less; do not feel well; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01Feb2021 at 15:30 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension benign. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), estradiol (MANUFACTURER UNKNOWN) and calcium citrate (CITRACAL); all for unknown indication from an unknown date and unknown if ongoing. On 02Feb2021 at 07:00, next day after vaccination when the patient woke up, experienced strong dizziness. Since then, the patient did not feel well and was dizzy, sometime more, sometimes less. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events strong dizziness, did not feel well and was dizzy was not recovered at the time of this report. The patient also received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 22Feb2021 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; ESTRADIOL; CITRACAL [CALCIUM CITRATE]

Current Illness:

ID: 1791652
Sex: F
Age:
State: OH

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Insomnia; waking up with panic attacks; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 26Feb2021 at 14:00 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient reported that she had already submitted these medications (unspecified) which she had received within two weeks of vaccination and also provided a details of allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Feb2021, the patient experienced insomnia and waking up with panic attacks. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with sleeping aid. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome for the events insomnia and waking up with panic attacks was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791653
Sex: F
Age:
State: PA

Vax Date: 02/25/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Arms hurts; "I" m starting to feel as if "Im getting a cold; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 16:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, contrast media allergy (allergy to contrast dye), food allergy (feed) and allergy to animal (hyena). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient took other medication in two weeks (Reg meds). The patient reported that he was fine until that day, 02Mar2021. On 02Mar2021, the patients arm hurts and the patient started to feel as if he was getting a cold. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm hurts and "I' m starting to feel as if I'm" getting a cold was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791654
Sex: F
Age:
State: FL

Vax Date: 03/01/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Pain at injection site; Chills; Body aches; Diarrhea; Nausea; Extreme fatigue; Stabbing pain in right lower abdomen; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6200) via an unspecified route of administration in the left arm on 01Mar2021 at 12:30 (at the age of 69-years old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis and COVID-19 (prior to the vaccination, the patient was diagnosed with COVID-19). The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. On 02Mar2021 at 02:00, the patient experienced pain at injection site, chills, body aches, diarrhea, nausea, extreme fatigue and stabbing pain in right lower abdomen. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain at injection site, chills, body aches, diarrhea, nausea, extreme fatigue and stabbing pain in right lower abdomen was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791655
Sex: F
Age:
State: WI

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Earache; Mild headache; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Mar2021 at 16:00 (at the age of 49-year-old), as a single dose for COVID-19 immunisation. The patient's medical history was unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received oseltamivir phosphate (TAMIFLU) and sulfur (MANUFACTURER UNKNOWN); both for unspecified indications from unknown dates and experienced drug allergy. On 02Mar2021 at 17:15, the patient experienced earache and mild headache. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events earache and mild headache was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791656
Sex: F
Age:
State:

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 49-year-old (non-pregnant) female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 49, via an unspecified route of administration, on Mar 2, 2021, at 13:30, single dose, for COVID-19 immunisation. No medical history reported. No known allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not have any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the vaccination. On Mar 2, 2021, patient experienced a very deep sleep at the night after the vaccine. The day after the vaccine, patient felt sleepy as though like jetlagged. The events did not result in doctor or other healthcare professional office/clinic/emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. No therapeutic measures taken as a result of the event. The outcome of feeling sleepy: not recovered (at the time of this report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1791657
Sex: F
Age:
State: MI

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Migraine that will not go away along with nausea; Migraine that will not go away along with nausea; This is a spontaneous report from a contactable other healthcare professional, the patient. A 22-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Feb2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Feb2021, the patient experienced migraine that would not go away along with nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine that would not go away along with nausea was not resolved at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791658
Sex: F
Age:
State: DC

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: terrible vertigo; This is a spontaneous report from a contactable consumer. A non-pregnant female patient of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Feb2021 as a single dose for COVID-19 immunisation. Medical history included symptoms of having COVID-19, including muscle tremors, chills without (w/o) fever, joint pain and cough from an unspecified date in Feb2021 and unknown if ongoing. It was unknown if the patient had known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. It was unknown if the patient had received other medications in two weeks. On 26Feb2021, the patient experienced terrible vertigo. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event terrible vertigo was recovered on 01Mar2021, after the duration of 72 hours. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791659
Sex: F
Age:
State: TX

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Sore arm for approximately 30 hours - peak soreness at about 12-14 hours after injection; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 01Mar2021 at 15:45 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. On 01Mar2021 at 20:00, the patient experienced sore arm for approximately 30 hours - peak soreness at about 12-14 hours after injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolved on 03Mar2021 at 02:00. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; VALSARTAN; ESCITALOPRAM.

Current Illness:

ID: 1791660
Sex: F
Age:
State: FL

Vax Date: 02/16/2021
Onset Date: 02/23/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe muscle pain; Very sleepy; Tiredness; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9265) via an unspecified route of administration in the right arm on 16Feb2021 at 10:00 (at the age of 70-years-old) as a single dose for COVID-19 immunisation. Medical history included LDL cholesterol-high and known allergies only to lactose or caffeine. Concomitant medications included colecalciferol (VIT D3), ascorbic acid (VITAMIN C), menaquinone (VITAMIN K2) and zinc (MANUFACTURER UNKNOWN); all medications from an unknown date and unknown if ongoing for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an unspecified route of administration in the right arm on 19Jan2021 at 10:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 23Feb2021 at 04:00, the patient experienced severe muscle pain, very sleepy, tiredness and feeling unwell after the first week of the second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe muscle pain, very sleepy, tiredness and feeling unwell were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VIT D3; VITAMIN C [ASCORBIC ACID]; VITAMIN K2 [MENAQUINONE]; ZINC

Current Illness:

ID: 1791661
Sex: F
Age:
State: TX

Vax Date: 02/28/2021
Onset Date: 03/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Swollen lymph node on injection arm (left side); This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Feb2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not received any other vaccines within four weeks prior to the vaccination. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and water pill (unspecified); both for unknown indication from unknown date and unknown if ongoing. On 01Mar2021 at 07:00, the patient experienced swollen lymph node on injection arm (left side). The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node on injection arm (left side) was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LOSARTAN

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am